Portugal
Tuberculosis profile
Population  2013 11 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.14 (0.14–0.15) 1.3 (1.3–1.4)
Mortality (HIV+TB only) 0.061 (0.04–0.086) 0.58 (0.38–0.81)
Prevalence  (includes HIV+TB) 3.1 (1.4–5.5) 30 (13–52)
Incidence  (includes HIV+TB) 2.7 (2.5–3) 26 (24–28)
Incidence (HIV+TB only) 0.5 (0.49–0.5) 4.7 (4.6–4.8)
Case detection, all forms (%) 85 (78–92)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.98 (0.51–1.7) 4.9 (1.6–11)
MDR-TB cases among notified pulmonary
TB cases
15 (8–27) 8 (3–17)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 1 377   91
Pulmonary, clinically diagnosed 186   11
Extrapulmonary 646   27
       
Total new and relapse 2 338    
Previously treated, excluding relapses 55    
Total cases notified 2 393    
Among 2 338 new and relapse cases:
48 (2%) cases aged under 15 years; male:female ratio: 1.8
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 894 (65%) 56 (30%) 944
Laboratory-confirmed RR-/MDR-TB cases     16
Patients started on MDR-TB treatment     15
TB/HIV 2013 Number (%)
TB patients with known HIV status 1 522 (64)
HIV-positive TB patients 245 (16)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 78
Previously treated cases, excluding relapse, registered in 2012 77
HIV-positive TB cases, all types, registered in 2012 60
RR-/MDR-TB cases started on second-line treatment in 2011 52
XDR-TB cases started on second-line treatment in 2011 56
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 6.5
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-28 Data: www.who.int/tb/data